These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 8957106)

  • 1. Use of recombinant proteins in the diagnosis of autoimmune connective tissue diseases.
    Galperin C; Coppel RL; Gershwin ME
    Int Arch Allergy Immunol; 1996 Dec; 111(4):337-47. PubMed ID: 8957106
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Differentiation of autoantibodies to extractable nuclear antigens using immunoblotting in various collagen diseases].
    Riemekasten G; Hiepe F
    Z Arztl Fortbild (Jena); 1992 Mar; 86(5):217-22. PubMed ID: 1585674
    [No Abstract]   [Full Text] [Related]  

  • 3. Estimating the incidence of connective tissue diseases and vasculitides in a defined population in Northern Savo area in 2010.
    Elfving P; Marjoniemi O; Niinisalo H; Kononoff A; Arstila L; Savolainen E; Rutanen J; Kaipiainen-Seppänen O
    Rheumatol Int; 2016 Jul; 36(7):917-24. PubMed ID: 27053177
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Connective tissue diseases: advances in diagnosis and management.
    Vyse TJ; Walport MJ
    Br J Hosp Med; 1993 Jul 14-Aug 17; 50(2-3):121-32. PubMed ID: 8353664
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Detection of anti-ENA autoantibodies in patients with systemic connective tissue diseases. Analytical variability and diagnostic sensitivity of 4 methods].
    Villalta D; Bizzaro N; Tonutti E; Visentin D; Manoni F; Piazza A; Toffolo L; Rizzotti P; Clemen P; Pradella M; Bassetti D; Tozzoli R
    Recenti Prog Med; 1999 Nov; 90(11):579-84. PubMed ID: 10608146
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The diagnosis and classification of undifferentiated connective tissue diseases.
    Mosca M; Tani C; Vagnani S; Carli L; Bombardieri S
    J Autoimmun; 2014; 48-49():50-2. PubMed ID: 24518855
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intracellular autoantigens: diagnostic fingerprints but aetiological dilemmas.
    Tan EM; Reimer G; Sullivan K
    Ciba Found Symp; 1987; 129():25-42. PubMed ID: 3315505
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An updated review of anti-Ro52 (TRIM21) antibodies impact in connective tissue diseases clinical management.
    Decker P; Moulinet T; Pontille F; Cravat M; De Carvalho Bittencourt M; Jaussaud R
    Autoimmun Rev; 2022 Mar; 21(3):103013. PubMed ID: 34896652
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical aspects of indirect immunofluorescence for autoimmune diseases.
    Ghanadan A; Saghazadeh A; Jahanzad I; Rezaei N
    Expert Rev Clin Immunol; 2015 May; 11(5):597-616. PubMed ID: 25786676
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The significance of some immunoserologic diagnostic tests in systemic diseases.
    Rozman B; Kveder T; Lestan B
    Acta Med Austriaca; 1988; 15(5):148-9. PubMed ID: 3265251
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship of Sjögren's syndrome to other connective tissue and autoimmune disorders.
    Theander E; Jacobsson LT
    Rheum Dis Clin North Am; 2008 Nov; 34(4):935-47, viii-ix. PubMed ID: 18984413
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantitative radioligand assays using de novo-synthesized recombinant autoantigens in connective tissue diseases: new tools to approach the pathogenic significance of anti-RNP antibodies in rheumatic diseases.
    Yamamoto AM; Amoura Z; Johannet C; Jeronimo AL; Campos H; Koutouzov S; Piette JC; Bach JF
    Arthritis Rheum; 2000 Mar; 43(3):689-98. PubMed ID: 10728764
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Five-year follow-up of 665 Hungarian patients with undifferentiated connective tissue disease (UCTD).
    Bodolay E; Csiki Z; Szekanecz Z; Ben T; Kiss E; Zeher M; Szücs G; Dankó K; Szegedi G
    Clin Exp Rheumatol; 2003; 21(3):313-20. PubMed ID: 12846049
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Altered Th17 cells and Th17/regulatory T-cell ratios indicate the subsequent conversion from undifferentiated connective tissue disease to definitive systemic autoimmune disorders.
    Szodoray P; Nakken B; Barath S; Csipo I; Nagy G; El-Hage F; Osnes LT; Szegedi G; Bodolay E
    Hum Immunol; 2013 Dec; 74(12):1510-8. PubMed ID: 23974054
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of autoantibodies in a quantitative immunoassay using recombinant ribonucleoprotein antigens.
    Habets WJ; Hoet MH; Sillekens PT; De Rooij DJ; Van de Putte LB; Van Venrooij WJ
    Clin Exp Immunol; 1989 May; 76(2):172-7. PubMed ID: 2527098
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Autoantibodies in Common Connective Tissue Diseases: A Primer for Laboratory Professionals.
    Martin J; Petryayeva E; Khan WI
    J Appl Lab Med; 2022 Jan; 7(1):114-136. PubMed ID: 34996077
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An update of neurological manifestations of vasculitides and connective tissue diseases: a literature review.
    Bougea A; Anagnostou E; Spandideas N; Triantafyllou N; Kararizou E
    Einstein (Sao Paulo); 2015; 13(4):627-35. PubMed ID: 26313435
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Wounds in autoimmune bullous dermatoses and systemic connective tissue diseases].
    Marinović B; Jukić IL; Lipozencić J
    Acta Med Croatica; 2012 Oct; 66 Suppl 1():13-7. PubMed ID: 23193815
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The SL/Ki system in connective tissue diseases: incidence and clinical associations.
    Riboldi P; Asero R; Origgi L; Crespi S
    Clin Exp Rheumatol; 1987; 5(1):29-33. PubMed ID: 3594962
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [How can the autoantibody detection help in the diagnostics and evaluation of autoimmune rheumatic diseases?].
    Vencovský J
    Vnitr Lek; 2006; 52(7-8):697-701. PubMed ID: 16967611
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.